Pliant Therapeutics, Inc. (PLRX)
NASDAQ: PLRX · Real-Time Price · USD
1.370
+0.020 (1.48%)
At close: Apr 1, 2025, 4:00 PM
1.365
-0.005 (-0.36%)
After-hours: Apr 1, 2025, 7:56 PM EDT
Pliant Therapeutics Employees
Pliant Therapeutics had 171 employees as of December 31, 2024. The number of employees increased by 13 or 8.23% compared to the previous year.
Employees
171
Change (1Y)
13
Growth (1Y)
8.23%
Revenue / Employee
n/a
Profits / Employee
-$1,229,848
Market Cap
83.89M
Employees Chart
Related Stocks
| Company Name | Employees |
|---|---|
| UnitedHealth Group | 400,000 |
| Johnson & Johnson | 138,100 |
| Thermo Fisher Scientific | 125,000 |
| Abbott Laboratories | 114,000 |
| AstraZeneca | 92,900 |
| Novo Nordisk | 77,349 |
| Novartis AG | 75,883 |
| Merck & Co. | 75,000 |
PLRX News
- 15 days ago - Pliant Therapeutics Announces Interim Phase 1 Data for PLN-101095 in Patients with Immune Checkpoint Inhibitor-Refractory Advanced Solid Tumors - GlobeNewsWire
- 19 days ago - SHAREHOLDER REMINDER: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Pliant Therapeutics - PRNewsWire
- 19 days ago - Pliant Therapeutics Adopts Limited Duration Stockholder Rights Agreement - GlobeNewsWire
- 4 weeks ago - Pliant Therapeutics Provides Corporate Update and Reports Fourth Quarter 2024 Financial Results - GlobeNewsWire
- 4 weeks ago - Pliant Therapeutics Stock Sinks, Discontinues Mid-Stage Study For Lung Disorder - Benzinga
- 4 weeks ago - Pliant Therapeutics Provides Update on BEACON-IPF, a Phase 2b/3 Trial in Patients with Idiopathic Pulmonary Fibrosis - GlobeNewsWire
- 4 weeks ago - The Schall Law Firm Invites Shareholders With Losses In Pliant Therapeutics, Inc. To Join A Securities Fraud Investigation - Accesswire
- 4 weeks ago - Bronstein, Gewirtz & Grossman, LLC Encourages Pliant Therapeutics, Inc. (PLRX) Shareholders to Inquire about Securities Investigation - Accesswire